This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

PharmaPoint: Rheumatoid Arthritis - India Drug Forecast And Market Analysis Event-Driven Update

Table 24: Key Events Impacting Sales for Rheumatoid Arthritis in India, 2012 62



Table 25: Rheumatoid Arthritis Market - Drivers and Barriers in India, 2012 63



Table 26: Key Launch Dates 75



Table 27: Key Patent Expiries 75



Table 28: Physicians Surveyed, By Country 81

List of Figures

Figure 1: Healthy and Arthritic Joint with Rheumatoid Arthritis 10



Figure 2: Rheumatoid Arthritis Biologic Drug Targets 12



Figure 3: Diagnosis Criteria for Rheumatoid Arthritis Based on 2010 ACR/EULAR Criteria Point System 17



Figure 4: Severity of Rheumatoid Arthritis 17



Figure 5: Biologic Treatment Flow Based on Updated 2012 ACR Treatment Recommendations* 20



Figure 6: Competitive Assessment of Late-Stage Pipeline Agents in RA, 2012-2022 59



Figure 7: Sales for Rheumatoid Arthritis in India by Drug Class 61

To order this report: Pathology Industry: PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis Event-Driven Update

__________________________



Nicolas BombourgReportlinkerEmail: nicolasbombourg@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626

 

 

SOURCE Reportlinker

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
4 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,090.18 +52.21 0.29%
S&P 500 2,110.93 +2.01 0.10%
NASDAQ 5,058.6310 -1.6150 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs